CanVirex is a spin-off from the Heidelberg University Hospital, founded in 2017 in Basel, Switzerland. The company develops novel immunotherapeutics for the treatment of cancer and is ready for the clinical translation of its proprietary cutting-edge..
Relevance: 24.585274